Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05835141 · ClinicalTrials.gov registry record

Rates and Risk Factors of Contact Between the OTX-TIC Intracameral Ocular Implant and Corneal Endothelium

A clinical trial, sponsored by University of Southern California.

Completed
Registry status
100
Enrollment target

NCT05835141 is a clinical trial that has completed, run by University of Southern California. The registered enrollment target is 100 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05835141 has completed, sponsored by University of Southern California.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

To determine what proportion of patients have inferior angle recess dimensions that could accommodate the OTX-TIC, and what are risk factors for implant contact with the corneal endothelium.

Interventions

  • OTHER OCT Imaging

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2023-05-01
Est. Completion 2024-05-31

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT05835141

The ClinicalTrials.gov registry entry for NCT05835141 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which OCT Imaging is the first listed.

NCT05835141 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05835141 about?

NCT05835141 is a clinical study titled "Rates and Risk Factors of Contact Between the OTX-TIC Intracameral Ocular Implant and Corneal Endothelium". To determine what proportion of patients have inferior angle recess dimensions that could accommodate the OTX-TIC, and what are risk factors for implant contact with the corneal endothelium.

What is the current status of trial NCT05835141?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2023-05-01. Estimated completion is 2024-05-31.

What interventions are being tested in trial NCT05835141?

The interventions under investigation include: OCT Imaging (OTHER).

Who is sponsoring clinical trial NCT05835141?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.